MKI67 and neoplasm: The efficiency of RRM2 in predicting the outcome for patients with ER-negative breast cancer was compared with other prognostic markers for this subtype including ki-67, HER2, tumor invasiveness, lymph node involvement, distant organ metastasis, Elson histological stage and uPA.